BELIEVE financials
BELIEVE
969500WGEAZ8YE4UAI86 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Cost of sales | €655.6M | €596.1M |
| Net finance income / (cost) | €7.3M | €10.5M |
| Profit before tax | €5.2M | -€7.5M |
| Income tax expense | €4.6M | -€4.9M |
| Profit for the year | €594.0K | -€2.7M |
| — attributable to owners | -€3.1M | -€5.5M |
| — attributable to NCI | €3.6M | €2.8M |
| Total comprehensive income | €2.4M | -€15.5M |
| Per share | ||
| Basic EPS | €-0.03 | €-0.06 |
| Diluted EPS | €-0.03 | €-0.06 |
| Cash flow statement | ||
| Net cash from operating activities | €21.9M | €12.7M |
| Net cash from investing activities | -€71.0M | -€86.9M |
| Net cash from financing activities | -€36.2M | -€5.0M |
| Proceeds from borrowings | €35.0M | €0 |
| Repayments of borrowings | €35.9M | €1.7M |
| Lease liability payments | €11.2M | €10.6M |
| Net change in cash | -€85.2M | -€79.2M |
| Balance sheet | ||
| Total assets | €1.17B | €1.11B |
| Non-current assets | €635.8M | €541.7M |
| Intangible assets & goodwill | €148.0M | €141.2M |
| Current assets | €536.1M | €565.4M |
| Inventories | €4.0M | €4.1M |
| Trade & other receivables | €249.5M | €200.2M |
| Cash & equivalents | €139.8M | €214.2M |
| Total equity | €360.5M | €379.2M |
| — attributable to owners | €359.3M | €370.8M |
| Non-controlling interests | €1.2M | €8.4M |
| Non-current liabilities | €54.9M | €59.1M |
| Current liabilities | €756.5M | €668.7M |
| Deferred tax liabilities | €19.8M | €20.7M |
| Derived metrics | ||
| Net margin | 0.1% | -0.3% |
| Return on equity | 0.2% | -0.7% |
| Cash conversion ratio | 36.92× | -4.73× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €50.4M | €61.3M |
| Adjustments For Income Tax Expense | €4.6M | -€4.9M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€38.0K | -€1.0M |
| Adjustments For Provisions | €761.0K | €180.0K |
| Adjustments For Sharebased Payments | €8.0M | €8.0M |
| Bank Overdrafts Classified As Cash Equivalents | €0 | €0 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €139.8M | €214.2M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €24.9M | €36.6M |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.8M | -€1.7M |
| Comprehensive Income Attributable To Owners of Parent | €605.0K | -€13.8M |
| Current Provisions | €1.8M | €1.6M |
| Current Tax Assets Current | €4.3M | €4.1M |
| Current Tax Liabilities Current | €4.6M | €4.4M |
| Deferred Tax Assets | €24.4M | €20.1M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €10.8M | -€9.9M |
| Equity and Liabilities | €1.17B | €1.11B |
| General and Administrative Expense | €56.1M | €54.5M |
| Income Taxes Paid Refund Classified As Operating Activities | €9.4M | €5.6M |
| Increase Decrease In Number of Shares Outstanding | — | 0.3M |
| Increase Decrease In Working Capital | €24.6M | €23.7M |
| Increase Decrease Through Sharebased Payment Transactions | €6.7M | €7.1M |
| Increase Decrease Through Transfers and Other Changes Equity | €0 | €1.2M |
| Increase Decrease Through Treasury Share Transactions | €163.0K | €178.0K |
| Intangible Assets Other Than Goodwill | €146.5M | €135.6M |
| Investment Accounted For Using Equity Method | €71.9M | €48.8M |
| Issue of Equity | €11.3M | €1.6M |
| Issued Capital | €503.0K | €485.0K |
| Noncurrent Financial Assets | €11.2M | €9.6M |
| Noncurrent Provisions | €620.0K | €409.0K |
| Number of Shares Outstanding | 100.6M | 97.1M |
| Other Adjustments For Noncash Items | -€8.2M | -€15.8M |
| Other Comprehensive Income | €1.8M | -€12.9M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €2.0M | -€13.3M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€122.0K | €454.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €2.0M | -€13.3M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€122.0K | €454.0K |
| Other Current Assets | €34.6M | €38.3M |
| Other Current Financial Assets | €4.0M | €1.4M |
| Other Current Liabilities | €53.4M | €40.6M |
| Other Finance Income Cost | €5.7M | €6.3M |
| Other Noncurrent Liabilities | €5.2M | €16.5M |
| Other Operating Income Expense | -€10.1M | €1.7M |
| Payments From Changes In Ownership Interests In Subsidiaries | €39.3M | €0 |
| Proceeds From Issuing Shares | €11.3M | €1.6M |
| Reduction of Issued Capital | €0 | — |
| Reserve of Exchange Differences On Translation | -€31.4M | -€21.9M |
| Revenue From Contracts With Customers | €988.8M | €880.3M |
| Sales and Marketing Expense | €203.9M | €192.7M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €820.0K | -€301.0K |
| Share Premium | €480.6M | €470.3M |
| Treasury Shares | €0 | €1.1M |
Every line item above is a fact tagged in BELIEVE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.